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ABSTRACT
Werner syndrome (WS) is a premature aging disor-
der caused by mutations in the WS gene (WRN).
Although WRN has been suggested to play an
important role in DNA metabolic pathways, such
as recombination, replication and repair, its precise
role still remains to be determined. WRN possesses
ATPase, helicase and exonuclease activities.
Previous studies have shown that the WRN exonu-
clease is inhibited in vitro by certain lesions induced
by oxidative stress and positioned in the digested
strand of the substrate. The presence of the 70/86
Ku heterodimer (Ku), participating in the repair
of double-strand breaks (DSBs), alleviates WRN
exonuclease blockage imposed by the oxidatively
induced DNA lesions. The current study demon-
strates that WRN exonuclease is inhibited by several
additional oxidized bases, and that Ku stimulates
the WRN exonuclease to bypass these lesions.
Specific lesions present in the non-digested strand
were shown also to inhibit the progression of
the WRN exonuclease; however, Ku was not able
to stimulate WRN exonuclease to bypass these
lesions. Thus, this study considerably broadens
the spectrum of lesions which block WRN exonu-
clease progression, shows a blocking effect of
lesions in the non-digested strand, and supports a
function for WRN and Ku in a DNA damage proces-
sing pathway.
INTRODUCTION
Accumulation of oxidatively induced DNA damage has
been implicated in cancer, aging and neurodegenerative
diseases (1). The ability to remove oxidatively damaged
DNA is essential for maintaining proper cellular functions
and genome integrity. Base excision repair (BER) is
the predominant pathway responsible for the removal of
DNA damage induced by oxidative stress, via the sequen-
tial actions of a DNA glycosylase, apurinic/apyrimidinic
endonuclease (APE1), DNA polymerase and DNA
ligase (2).
A large number of diﬀerent lesions is produced in DNA
by hydroxyl radicals generated by ionizing radiation
and metal-ion-catalyzed Fenton reactions (3). Major
products of purine oxidation are 7,8-dihydro-8-oxogua-
nine (8oxo-Gua), 7,8-dihydro-8-oxoadenine (8oxo-Ade)
and 2-oxoadenine (2OH-Ade), as well as imidazole
ring-opened Fapy lesions, 2,6-diamino-4-hydroxy-5-for-
mamidopyrimidine (Fapy-Gua) and 4,6-diamino-5-forma-
midopyrimidine (Fapy-Ade). Depending on the reaction
conditions, such as the presence or absence of oxygen and
presence of reducing agents etc., the proportion between
these oxidized purines may vary (4,5). 8oxo-Gua, 8oxo-
and 2OH-Ade are characterized by strong miscoding
potential and weak blocking of DNA synthesis (6–8).
Fapy-Ade and Fapy-Gua moderately block selected
DNA polymerases in vitro, and eﬃciently cause incorpora-
tion of non-cognate nucleotides (9–11). However, in E.coli,
FapyGua was shown to be strongly mutagenic and was
bypassed by replicative DNA polymerase with the eﬃ-
ciency similar to that of 8oxo-Gua (12,13). FapyGua was
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was only weakly mutagenic in these cells (14). Elevated
levels of all these lesions have been found in diﬀerent
types of human cancers (3,5,15,16).
The two most common oxidized cytosine derivatives
are 5-hydroxycytosine (5OH-Cyt) and 5-hydroxyuracil
(5OH-Ura). The levels of oxidized cytosine in DNA
after g-irradiation can be as high as those of 8oxo-Gua
(17), and oxidized cytosines have been shown to be highly
miscoding. They eﬀectively induce GC!AT transitions,
which are the most frequently occurring base substitution
mutations in aerobic organisms (18). Increased levels of
5OH-Cyt and 5OH-Ura have been found in several types
of cancers (3,5,19).
Another pyrimidine lesion, 5-hydroxymethyluracil
(5OHMe-Ura), can be formed from reactive oxygen spe-
cies (ROS)-damaged thymine, or from oxidized and deam-
inated 5-methylcytosine, which is often present in CpG
islands in promoter regions of the genome (2).
Formation of 5OHMe-Ura from 5-methylcytosine could
be particularly important, as altered methylation may play
a role in the development of cancer and aging (2).
Interestingly, reduced levels of 5OHMe-Ura DNA glyco-
sylase were found in cells from patients suﬀering from the
premature aging syndrome Werner Syndrome (WS) (20).
WS is a human autosomal recessive disorder, which is
characterized by the premature onset of phenotypical
changes associated with normal aging, as well as an
increased frequency of cancers (21). The gene responsible
for WS encodes a 1432 aa protein, WRN, which belongs
to the evolutionary conserved family of RecQ helicases
(22). All RecQ helicases possess an ATP-dependent 30 to
50 helicase activity (23). In contrast to other human RecQ
family members, WRN also possesses a 30 to 50 exonu-
clease activity (22), which shares homology with the
human DnaQ family of replicative proofreading exonu-
cleases (24) and RNase D from E. coli (25). Several
nucleases have been demonstrated to participate in
DNA repair. Although WRN interacts with proteins
required for DNA repair, transcription, replication and
telomere maintenance (21,23,26), the precise roles of the
two enzymatic activities of WRN have still not been fully
elucidated. WRN interacts with several oxidatively stress-
related factors (27) and in contrast to normal human
ﬁbroblasts, WS ﬁbroblasts continue to proliferate after
extensive H2O2-induced DNA damage, whereby oxida-
tion-induced lesions accumulate (28).
Cells derived from WS patients display premature
replicative senescence, as do cells lacking any of the two
subunits of the 70/86 Ku heterodimer (Ku) (29,30). Ku is a
component of the DNA-PK complex required for the
repair of DNA double-strand breaks (DSBs), via the
non-homologous end joining (NHEJ) pathway. In addi-
tion to its role in DNA repair, Ku is also involved in
transcription, chromatin silencing and telomere biology
(31,32). Interestingly, Ku interacts with WRN and selec-
tively stimulates its exonuclease activity on a substrate
mimicking a DSB repair intermediate (33,34). Further-
more, interaction with Ku increases the processivity of
the WRN exonuclease, allowing digestion of DNA struc-
tures, which the WRN exonuclease is not able to digest by
itself (33,34). Moreover, studies from our group have
shown that in the presence of Ku, WRN exonuclease
is able to bypass certain oxidatively induced DNA lesions
(35). This interaction has been suggested to play an impor-
tant role in the processing of 30 ends of duplex DNA
during the repair of strand breaks (35). As both Ku and
WRN localize to telomeres (36,37), the interaction
between these two proteins may also be signiﬁcant for
telomere maintenance and processing.
It has previously been demonstrated that oxidative
stress eﬃciently induces DNA damage at the telomere
(38,39), and it is believed that this damage plays an impor-
tant role in telomere shortening with age. Since our knowl-
edge about the role of speciﬁc DNA lesions in this process
is limited, we have here extended our previous studies with
a selection of duplex DNA oligonucleotide substrates
harbouring a variety of oxidatively induced DNA base
lesions, in order to investigate the inﬂuence of these lesions
on the progression of the WRN exonuclease.
Furthermore, we have made comparisons to human
APE1, another prominent human 30 to 50 exonuclease,
which is a very abundant protein in human cells. APE1
plays an important role in the repair of DNA base lesions
via the BER pathway, and we aimed to examine, whether
it may play a role as a sensor of oxidative damage pro-
posed previously for WRN exonuclease (40). We found
that only the exonuclease activity of WRN, and not of
APE1, was signiﬁcantly inhibited by 5OH-Ura and
5OH-Cyt lesions positioned in the digested strand of the
DNA substrate. WRN exonuclease blockage at these
lesions was alleviated by the addition of Ku, but the Ku
stimulation of WRN exonuclease was not due to stabiliza-
tion of WRN binding to DNA. Moreover, we observed
that oxidatively induced DNA lesions positioned in the
non-digested strand, including abasic sites (AP site) and
5OH-Ura, also aﬀected the progression of the WRN exo-
nuclease. In contrast, we did not observe such blockage in
the case of APE1. Interestingly, we found that Ku was not
able to stimulate WRN bypass of these base lesions in the
non-digested strand. These ﬁndings provide new insights
into the mechanisms of WRN exonuclease activity during
DNA metabolic events related to DNA repair and telo-
mere maintenance.
MATERIALS AND METHODS
Proteins
Recombinant His-tagged WRN and Ku protein were pur-
iﬁed using an insect cell expression system, as described
previously (37,41). Brieﬂy, recombinant human WRN was
over-expressed in insect cells and puriﬁed by chromatogra-
phy, using DEAE-Sepharose, Q-Sepharose and Ni-NTA
columns. The purity of WRN was checked by SDS-PAGE
and Coomassie staining. Human wild-type Ku was puri-
ﬁed using Ni-NTA, MonoQ HR5/5 chromatography and
native DNA cellulose column, as previously described
(41). Ku preparations were later tested for the presence
of contaminating nucleic acids (41). Human recombinant
APE1 protein was kindly provided by Dr David Wilson
(National Institute on Aging, Baltimore) (42,43).
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Oligodeoxynucleotides with and without modiﬁed bases
were purchased from DNA Technology, Aarhus,
Denmark, except the oligonucleotide fragments contain-
ing the Fapy-G and Fapy-A lesions (G-16-mer and
A-30-mer), which were kindly provided by Prof.
Dr Marc M. Greenberg (Department of Chemistry,
Johns Hopkins University, Baltimore, MD, USA).
Oligonucleotide sequences are presented in Tables 1–3.
Labelling of oligonucleotides
Oligonucleotides (10mM) were puriﬁed employing pre-
parative gel electrophoresis and 20pmol oligonucleotide
was then radiolabelled in reaction buﬀer containing
1 PNK reaction buﬀer (50mM Tris-HCl (pH 7.6 at
258C), 10mM MgCl2, 5mM DTT, 0.1mM spermidine
and 0.1mM EDTA; Fermentas), 2ml[ g-
32P]-ATP
(160mCi/ml, Life Science, Denmark) and 2ml PNK
(10U/ml, Fermentas). The reaction was incubated for
90min at 378C. Subsequently, the products were puriﬁed
on a G25 Sephadex column (Molecular Imaging,
Amersham). Ten picomoles of the radiolabelled strand
was then duplexed with an equal amount of the comple-
mentary non-labelled strand, to a ﬁnal concentration of
200 fmol/ml (200mM). Radiolabelled oligonucleotides were
stored at 48C.
In some cases, radiolabelled duplexed oligonucleotides
were further puriﬁed. Brieﬂy, radiolabelled oligonucleo-
tide (20pmol) was incubated overnight with a 5-fold
excess of the unlabelled strand. The duplexed oligonucleo-
tides were separated from the single-stranded DNA by
Table 1. Oligonucleotides used to generate double stranded 30-recessed
DNA substrates
32-mer (undamaged):
5′ TGA CGT GAC GAC GAT CAG GGT ACG TTC AGC AG 3′
32-mer 5OH-Cyt:
5′ TGA CGT GAC GAC GAT CAG GGT ACG TTx AGC AG 3′ x=5-hydroxycytosine 
32-mer 5OH-Ura:
5′ TGA CGT GAC GAC GAT CAG GGT ACG TxC AGC AG 3′ x=5-hydroxyuracil
43-mer (bottom strand):
5′ AGT GCA GAC TGC TGC TGA ACG TAC CCT GAT CGT CGT CAC GTC A 3′
3′
3′
5′
5′
32-mer
43-mer
Recessed substrate
Table 2. Oligonucleotides used to generate double stranded forked DNA substrates
TelX (undamaged):
Forked substrate
5′ TTT TTT TTT TTT TTT GGT GAT GGT GTA TTG AGT GGG ATG CAT  GCA CTA C 3′
TelX-8oxo-Gua:
5′ TTT TTT TTT TTT TTT GGT GAT GGT GTA TTG AGT GGG ATx CAT  GCA CTA C 3′ x=8-hydroxyguanine
TelX-5OH-Cyt:
5′ TTT TTT TTT TTT TTT GGT GAT GGT GTA TTG AGT GGG ATG xAT GCA CTA C 3′ x=5-hydroxycytosine
TelX8oxo-Ade:
5′ TTT TTT TTT TTT TTT GGT GAT GGT GTA TTG AGT GGG ATG CxTG C A  C T A  C  3 ′ x=8-oxoadenine
TelX-5OH-Ura:
5′ TTT TTT TTT TTT TTT GGT GAT GGT GTA TTG AGT GGG ATG xAT GCA CTA C 3′ x=5-hydroxyuracil
TelX-5OHMe-Ura:
5′ TTT TTT TTT TTT TTT GGT GAT GGT GTA TTG AGT GGG ATG xAT GCA CTA C 3′ x=5-hydroxymethyluracil
TelX-2OH-Ade:
5′ TTT TTT TTT TTT TTT GGT GAT GGT GTA TTG AGT GGG ATG CxTG C A  C T A  C  3 ′ x=2-hydroxyadenine
TelY (undamaged bottom strand):
5′ GTA GTG CAT GCA TCC CAC TCA ATA CAC CAT CAC CTT TTT TTT TTT TTT T 3′
TelY-8oxo-Gua:
5′ GTA GTG CAT xCA TCC CAC TCA ATA CAC CAT CAC CTT TTT TTT TTT TTT T 3′ x=8-hydroxyguanine
TelY-5OH-Ura:
5′ GTA GTG xAT GCA TCC CAC TCA ATA CAC CAT CAC CTT TTT TTT TTT TTT T 3′ x=5-hydroxycytosine 
TelY-APsite: 
5′ GTA GTG CAx GCA TCC CAC TCA ATA CAC CAT CAC CTT TTT TTT TTT TTT T 3′ x=abasic site analog (dSpacer)
Tel Y
Tel X 5′
3′
5′
3′
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labelled duplex was eluted from the gel, ethanol precipi-
tated, resuspended in a ﬁnal volume of 20mlH 2O and
stored at 48C.
Labelling and purification ofoligonucleotides containing
Fapy-Guaand Fapy-Ade lesions
Oligodeoxynucleotides containing Fapy lesion (kindly
provided by Dr M. Greenberg) were too short
(FapyGua—16-mer, FapyAde—30-mer) for the construc-
tion of the WRN substrate. Therefore, these fragments
were elongated by ligation with oligodeoxynucleotides of
appropriate lengths (50 end fragments: G—33-mer, A—24-
mer), which were complementary to undamaged bottom
strand (49-mer for oligo-containing Fapy-G or 54-mer for
oligo-containing Fapy-A). The formed substrates were
forked and had a similar duplex length to the substrates
used in the previous assays. As a control, the same sub-
strates were prepared, however without Fapy lesions
(Table 3). Prior to ligation, 20pmol of the G-16-mer or
A-30-mer (undamaged or containing Fapy lesions, respec-
tively), was phosphorylated in reaction buﬀer containing
1 PNK buﬀer (Fermentas), 0,1mM ATP and 2ml PNK
(10U/ml, Fermentas). The reaction was incubated for
90min at 378C. In parallel, 30pmol of the G-33-mer or
A-24-mer oligos were radiolabelled for 90min at 378C,
in reaction buﬀer containing 1 PNK buﬀer (Fermentas),
2ml[ g-
32P]-ATP (160mCi/ml, Life Science, Denmark) and
2ml PNK (10U/ml, Fermentas). After phosphorylation,
DNA fragments were puriﬁed on a G25 Sephadex
column(MolecularImaging,Amersham).Fapy-containing
substrates were constructed by mixing 20pmol of the
phosphorylated G-16-mer or A-24-mer, 30pmol of the
radiolabelled G-33-mer or A-30-mer with 60pmol of
the respective cold bottom strand oligo (G-49-mer or
A-54-mer) in reaction buﬀer containing 1 ligase buﬀer
(New England Biolabs, UK). The oligos were annealed
by heating 5min at 808C, and allowed to cool down to
room temperature. After annealing, the top strand frag-
ments were ligated by adding 500U of the T4 DNA
ligase (New England Biolabs, UK) and ATP to a ﬁnal
concentration of 1mM, and incubating for 2h at 168C.
Subsequently, 30ml of FA buﬀer (80% formamide, 10mM
EDTA pH 8, 1mg/ml xylene cyanol and 1mg/ml bromo-
phenol blue) was added to the oligo mixture, the mixture
was denatured 5min at 808C, and the ligated top strand
of the substrate was separated from the non-ligated top
strand fragments by means of denaturing PAGE. The
full-length oligonucleotide was cut out of the gel and
eluted. After ethanol puriﬁcation, the DNA was resus-
pended in 9–20ml of TE buﬀer, depending on the yield of
puriﬁed DNA, and stored at 48C.
Table 3. Oligonucleotides used to generate double stranded forked DNA substrates containing Fapy lesions
Fapy-Gua oligo:
G-33-mer (5′ end fragment): 
5′: TTT TTT TTT TTT TTT GGT CAG CAT TAC CCT GCA 3′
G-16-mer-UNDAMAGED (3′ end fragment): 
5′-CCA GGT GCG AAG TGG T 3′
G-16-mer (3′ end fragment): 
5′-CCA GGT GCx AAG TGG T 3′ x=Fapy-Gua
G-49-mer (bottom strand):
5′ – ACC ACT TCG CAC CTG GTG CAG GGT AAT GCT GAC CTT TTT TTT TTT TTT T – 3′
Fapy-Ade oligo:
A-24-mer (5′ end fragment): 
5′ TTT TTT TTT TTT TTT GGT CAG CAT 3′
A 30-mer-UNDAMAGED (3′ end fragment):
5′-CGTTCAACGTGCACTAACAGCACGTCCCAT-3′  
A-30-mer (3′ end fragment):
5′-CGTTCAACGTGCACTxACAGCACGTCCCAT-3′ x=Fapy-Ade
A-54-mer (bottom strand): 
5′ ATG GGA CGT GCT GTT AGT GCA CGT TGA ACG ATG CTG ACC TTT TTT TTT TTT TTT 3   ′
bottom
strand
5′
3′
5′
3′
Forked substrate
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For assays with forked substrates, radiolabelled DNA
substrate (14 or 21 fmol for Fapy oligos) was diluted in
1 exonuclease reaction buﬀer (40mM Tris HCl pH 8;
4mM MgCl2; 5mM DTT and 1mg/ml BSA). Reactions
were initiated by the addition of WRN (0, 10, 20, 40, 60
fmol), incubated for 15min at 378C, and terminated with
10ml FA buﬀer. Reactions were heat-denatured for 5min
at 908C and reaction products were separated on a 14%
acrylamide denaturing gel. The gels were dried and
exposed to a phosphorimager screen. For reactions con-
taining Ku, recombinant Ku (7.5 fmol) was added to the
reaction prior to initiation of the reaction with WRN.
For assays with recessed substrates, the reaction buﬀer
was supplemented with 2mM ATP. Reactions were incu-
bated with WRN (0–240 fmol), in the presence or absence
of 128 fmol Ku, and incubated for 1h at 378C. Reactions
were terminated by the addition of 10ml FA buﬀer.
Reaction products were separated and visualized as
described above.
Quantification of WRN exonuclease blockage
For each concentration of WRN, the extent of bypass was
quantiﬁed by measuring the intensity of all bands below
the site of damage, relative to the total intensity of the
lane. For comparison between experiments, bypass of
the undamaged substrate was set to 1. Average values
are based on a minimum of 3 experiments for each
substrate.
APE1 exonuclease assay
Radiolabelled DNA substrate (13 fmol) was incubated in
exonuclease reaction buﬀer supplemented with 100fmol of
appropriate unlabelled double-stranded DNA. Reactions
were initiated by the addition of recombinant APE1
(0–50fmol), incubated for 15min at 378C, and terminated
with 10ml FA buﬀer. Reaction products were separated
and visualized as described above. For reactions contain-
ing Ku, the reaction buﬀer did not contain unlabelled
double-stranded DNA and Ku (7.5–45 fmol) was added
prior to APE1.
RESULTS
We have previously shown that certain modiﬁed nucleo-
tides, as well as abasic sites and bulky adducts, such as
cholesterol, located in the degraded strand of the DNA
substrate, severely inhibit the progression of the WRN
exonuclease (40). In addition, 8oxo-Ade and 8oxo-Gua,
two of the most frequent free-radical-induced purine
lesions, eﬃciently block WRN exonuclease on a 30
recessed substrate (40). In this report, we investigated
the inﬂuence of additional ROS-induced lesions on
WRN exonuclease activity. First, we determined whether
WRN exonuclease was aﬀected by oxidation products of
pyrimidines, such as 5OH-Cyt and 5OH-Ura. We intro-
duced the lesions into the recessed strand of the previously
used DNA substrate, as shown in Table 1, and measured
the degradation of this strand by WRN.
In the presence of increasing amounts of WRN, the
undamaged substrate was digested in proportion with
the WRN concentration (Figure 1A). In contrast, progres-
sion of WRN exonuclease activity was inhibited on sub-
strates containing 5OH-Ura and 5OH-Cyt. The blockage
of WRN exonuclease by these lesions was not relieved by
increasing the concentration of WRN, suggesting, that
similar to the situation for 8oxo-Gua and 8oxo-Ade, the
5OH-Cyt and 5OH-Ura lesions impose a steric hindrance
for WRN. For both lesions, the digestion was inhibited
one nucleotide 30 to the lesion (Figure 1A). This is in
agreement with previous reports on the inhibition of
WRN exonuclease by 8oxo-Gua and 8oxo-Ade (40).
Next, we investigated whether blockage of WRN exo-
nuclease activity by oxidatively induced DNA lesions was
structure speciﬁc. To address this, we used a forked sub-
strate containing a duplex fragment similar in length to
the recessed substrates used above (Tables 2 and 3). As
forked duplexes can be processed by both WRN exonu-
clease and helicase activities (44), we omitted ATP from
the reactions to focus solely on the exonuclease products
generated by WRN acting on the blunt end of this
substrate.
Exonuclease assays with forked substrates containing
8oxo-Ade and 8oxo-Gua in the digested strand are
shown in Figure 1B. In agreement with previous ﬁndings
using recessed substrates (40), we observed a dramatic
blockage of WRN exonuclease activity by 8oxo-Gua and
8oxo-Ade lesions in the forked duplexes. Almost no
digested products were observed beyond the position of
the lesion and the blockage occurred one nucleotide 30 to
the lesion (Figure 1B). The exonuclease activity of WRN
on forked substrates containing 5OH-Ura, 5OH-Cyt,
5OHMe-Ura and 2OH-Ade is presented in Figure 1C.
When compared to 8oxo-Gua and 8oxo-Ade, 5OH-Ura
and 5OH-Cyt blocked WRN exonuclease activity less
eﬀectively, as some exonuclease products were observed
beyond the position of the lesions in the substrate
(Figure 1C). In contrast to the lesions tested thus far,
5OHMe-Ura and 2OH-Ade did not signiﬁcantly block
progression of the WRN exonuclease, even at the lowest
WRN concentrations tested, but caused a slight pausing of
WRN exonuclease (Figure 1C).
Next, we investigated the eﬀects of Fapy-Gua or Fapy-
Ade lesions on the progression of WRN exonuclease.
Similar to the exonuclease assays with 8oxo-Gua and
8oxo-Ade, the Fapy-Gua lesion eﬀectively blocked
WRN exonuclease (Figure 1D), as only very few digested
products were observed beyond the position of the lesion.
The Fapy-Ade lesion also eﬀectively blocked the progres-
sion of WRN exonuclease. As observed for other sub-
strates, the blockage of WRN exonuclease occurred 30 to
the damaged nucleotide (Figure 1D).
The degree of WRN exonuclease blockage was quanti-
ﬁed for each damaged substrate. Thus, the amount of
digestion beyond the lesion was compared to the corre-
sponding position in the undamaged substrate, at 40 fmol
of WRN for substrates shown in Figure 1B and C, and at
the identical molar ratio of enzyme to substrate for the
Fapy-containing oligonucleotides (60 fmol WRN). The
bypass in the undamaged substrate was set to 100%,
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WRN 0 0 0
FORKED 
8oxo-Ade
0 WRN
FORKED
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0
FORKED
8oxo-Gua
0
WRN
FORKED
5OH-Cyt
0
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0
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5OH-Ura
0
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5OHMe-Ura
0 0
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Figure 1. WRN exonuclease activity on substrates containing 5OH-Ura and 5OH-Cyt in the digested strand of the substrate. (A) WRN exonuclease
blockage on recessed substrates. Recessed substrates (15fmol) containing undamaged (left panel) or 5OH-Cyt (middle panel) and 5OH-Ura (right
panel) in the digested strand were incubated in the absence or presence of WRN (0, 120 or 240fmol) as indicated, for 1h at 378C. Reaction products
were separated on a 14% polyacrylamide denaturing gel and visualized by phosphorimaging. (B–D) WRN exonuclease blockage on forked sub-
strates. Unmodiﬁed or modiﬁed DNA substrates (B,C—14fmol, D—21fmol), containing lesions in the digested strand of the substrate were
incubated with increasing amounts of WRN (10, 20, 40, 60fmol) for 15min at 378C. Reaction products were separated and visualized as described
in (A). Positions of the lesions are indicated by arrows. Und, undamaged; 8oxo-Ade, 8-oxoadenine; 8oxo-Gua, 8-oxoguanine; 5OH-Cyt, 5-hydro-
xycytosine; 5OH-Ura, 5-hydroxyuracil; 5OHMe-Ura, 5-hydroxymethyluracil; 2OH-Ade, 2-hydroxyadenine, Fapy-Gua, 2,6-diamino-4-hydroxy-
5-formamidopyrimidine; Fapy-Ade, 4,6-diamino-5-formamidopyrimidine.
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oligonucleotides was calculated. The most potent inhibi-
tors of WRN exonuclease progression were Fapy-Gua,
Fapy-Ade, 8oxo-Gua and 8oxo-Ade where the WRN
bypass was reduced by approximately 70% or more,
when compared to the unmodiﬁed substrate (Table 4).
5OH-Ura and 5OH-Cyt blocked the WRN exonuclease
to a lesser degree (40–50% reduction in WRN bypass),
allowing a moderate degree of bypass in both substrates.
The weakest blockage was observed with 5OHMe-Ura,
which had almost no inﬂuence on the progression of the
WRN exonuclease on the forked substrate.
We have previously shown that Ku interacts with WRN
and stimulates its exonuclease activity (34,45). Inhibition
of the WRN exonuclease by 8oxo-Ade and 8oxo-Gua
could be alleviated by the addition of Ku (35).
Therefore, we next investigated whether Ku could also
stimulate WRN digestion of substrates containing
5OH-Ura and 5OH-Cyt lesions.
As demonstrated above, WRN digestion of the unda-
maged substrate was proportional to the concentration of
WRN, while in the presence of 5OH-Ura and 5OH-Cyt,
WRN exonuclease progression was eﬃcient up to, but
not beyond, the modiﬁed nucleotides (Figure 2A).
Ku eﬃciently stimulated the 30 to 50 exonuclease activity
of WRN both on the undamaged and damaged
recessed substrates. On substrates containing 5OH-Cyt
and 5OH-Ura, the addition of Ku enhanced the exonu-
clease activity of WRN and allowed WRN exonuclease to
digest beyond the position of the lesion (Figure 2A, middle
and right panel).
Similar to the results with the recessed substrates, the
addition of Ku resulted in signiﬁcant stimulation of WRN
exonuclease activity on forked substrates containing
5OH-Ura and 5OH-Cyt (Figure 2B). Again, we observed
that WRN alone extensively digested the undamaged sub-
strate, while on the damaged substrates the progression of
WRN exonuclease was limited to the ﬁrst few nucleotides
prior to the DNA modiﬁcation (5OH-Ura, 5OH-Cyt or
8oxo-Gua). The addition of Ku facilitated WRN digestion
of the substrates containing 5OH-Cyt, 5OH-Ura and
8oxo-Gua, however pausing 30 to the site of the lesion
was still observed (Figure 2B). Thus, Ku also stimulated
WRN exonuclease to bypass the oxidatively induced
lesions 5OH-Ura and 5OH-Cyt in the context of forked
duplex substrates. In summary, the processivity of WRN
exonuclease activity is stimulated by Ku, whether or not a
lesion is present. Ku alone did not exhibit any exonuclease
activity on the substrate (Figure 2B).
Previous studies showed that Ku allows the digestion of
certain DNA structures that cannot be digested by WRN
alone (33,34). In addition, DNA-binding studies have
FORKED
54-mer UND
0 WRN
FORKED
49-mer UND
0
FORKED
49-mer Fapy-Gua
0
FORKED
54-mer Fapy-Ade
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D
Figure 1. Continued.
Nucleic Acids Research, 2008, Vol. 36, No. 15 4981shown that Ku eﬃciently recruits WRN to DNA (45,46),
suggesting that the mechanism of Ku stimulation may
involve stabilization of WRN binding to DNA. However,
trapping assays with WRN in the presence or absence of
Ku failed to conﬁrm these suggestions (data not shown).
Blockage of WRN exonuclease at oxidatively induced
lesions has previously been proposed to serve as a DNA
damage sensor (40), and therefore, we next addressed
whether this could be carried out by other human 30 to
50 exonucleases, such as APE1. APE1 is an abundant pro-
tein in human cells, and the major protein processing
abasic sites (AP sites) during BER, which is the predomi-
nant pathway for removing oxidatively modiﬁed bases
from DNA (47). Apart from its signiﬁcant AP-endonu-
clease activity, APE1 also possesses a 30 to 50 exonuclease
activity (47). In contrast to WRN, the APE1 exonuclease
was not found to be blocked by 8oxo-Gua and 8oxo-Ade
lesions in forked duplexes, but readily digested through
the damaged nucleotides (Figure 3A). 5OH-Cyt and
5OH-Ura resulted in some pausing of APE1 exonuclease
progression, and bands of higher intensities were visible at
the positions of these lesions (Figure 3A). However, the
intensity of the bands beyond the position of the lesion
indicated that even if the APE1 exonuclease paused at
these sites, it was still able to digest through these mod-
iﬁcations. Similar to the results obtained with the WRN
exonuclease, no inhibition of APE1 exonuclease activity
was observed using substrates containing 5OHMe-Ura
and 2OH-Ade (Figure 3A).
We next investigated the eﬀect of Ku on APE1 exonu-
clease activity. For both the undamaged substrate, and the
substrate containing a 5OH-Ura lesion, no diﬀerence in
the degree of digestion was observed between lanes
containing APE1 only, or APE1 and Ku (Figure 3B).
Thus, Ku did not stimulate APE1 exonuclease activity,
as it did for WRN, demonstrating the speciﬁcity of the
Ku stimulation of WRN exonuclease activity.
After investigating the eﬀect of ROS-induced lesions
located in the digested strand of the DNA substrate, we
next asked whether WRN exonuclease activity was
aﬀected by the presence of lesions in the non-digested
strand of the substrate. We used a forked duplex substrate
with a single 8oxo-Gua, 5OH-Ura or abasic site (AP site)
located in the non-digested strand (Table 2). The digestion
pattern of WRN on a substrate containing 8oxo-Gua in
the non-digested strand was similar to the digestion pat-
tern observed with the undamaged substrate (Figure 4A).
Quantiﬁcation of the digestion (Table 5) conﬁrmed that
8oxo-Gua in the non-digested strand did not have any
inﬂuence on the progression of the WRN exonuclease.
In contrast to 8oxo-Gua, WRN digestion of a substrate
containing an AP site resulted in pausing 1 nucleotide
before the DNA modiﬁcation (Figure 4A, lesion indicated
by an arrow), suggesting that an AP site in the non-
digested strand of the substrate impaired the progression
of the WRN exonuclease. The blockage was not robust, as
WRN was able to digest beyond the position of the lesion
(Figure 4A), without a signiﬁcant decrease in the amount
of total digested products (Table 5). Similar to results
observed for the lesion positioned in the digested strand
of the substrate (40), the position of the intense band was
30 of the modiﬁcation.
On substrates containing 5OH-Ura in the non-digested
strand, the WRN exonuclease digestion pattern produced
intense bands 30 to the lesion, indicating some inhibition of
the WRN exonuclease prior to the lesion (Figure 4A).
Bypass of this lesion was decreased to a moderate degree
(approximately 28% reduction in bypass), compared to
the undamaged substrate (Table 5).
Thus, we show here for the ﬁrst time, that certain base
lesions such as an abasic site and 5OH-Ura, positioned in
the non-digested strand of the DNA substrate, may retard
WRN exonuclease activity. In contrast, other lesions, such
as 8oxo-Gua, positioned in the non-digested strand, did
not inﬂuence the progression of the WRN exonuclease.
Having established the inﬂuence of modiﬁed nucleotides
in the non-digested strand on the exonuclease activity of
WRN, we addressed whether Ku could stimulate WRN
bypass of an AP-site or 5OH-Ura lesion located in the
non-digested strand. For substrates containing an
AP site and 5OH-Ura, the intensities of the bands sur-
rounding each lesion were similar both in the absence
and the presence of Ku (Figure 4B, note arrows), suggest-
ing that in contrast to the results obtained with lesions
positioned in the digested strand of the substrate,
Ku does not stimulate WRN exonuclease activity (i.e.
reduce stalling or pausing) on substrates containing
lesions in the non-digested strand.
DISCUSSION
In this report, we investigated WRN exonuclease activity
on two structure-speciﬁc substrates, each containing
Table 4. Blockage of WRN exonuclease progression by oxidative
lesions in the digested strand
Relative Passage (%)
Lesion Recessed Forked
aBased on Machwe et al., Nucleic Acids Res., 2000.
N/D: not determined.
4982 Nucleic Acids Research, 2008, Vol. 36, No. 15one of several diﬀerent free-radical-induced lesions posi-
tioned in the digested strand. We found that Fapy-Gua,
Fapy-Ade, 8oxo-Gua and 8oxo-Ade dramatically blocked
WRN exonuclease activity, while 5OH-Ura and 5OH-Cyt
inhibited WRN to a moderate degree, and 5OHMe-Ura
and 2OH-Ade only had a minor eﬀect. We included three
diﬀerent substrates to investigate whether sequence con-
text or structure aﬀected the degree of blockage by the
oxidatively induced lesions, and we observed similar
eﬀects regardless of the sequence or the structure of the
substrate (Table 4). As the recessed and forked substrates
resembled intermediates of diﬀerent pathways of DNA
metabolism (40,44), our results suggest that the progres-
sion of the WRN exonuclease may be blocked by
ROS-related DNA damage during processes such as
DNA repair, replication, recombination and/or telomere
maintenance.
In general, the greatest inhibition of WRN exonuclease
progression was seen with lesions which were derivatives
of purines, with a hydroxyl group close to the edge of the
major groove of DNA (Fapy lesions and 8-oxopurines)
(48). In contrast, pyrimidines with a C5 hydroxyl group,
positioned more centrally in the major groove, like
5OH-Ura and 5OH-Cyt, had less eﬀect on WRN
exonuclease.
Our results suggest that the presence of a hydroxyl
group precisely oriented in the major groove of the
DNA helix is essential for the ability of lesions to block
WRN, as lesions having the hydroxyl groups facing the
minor groove of DNA (2OH-Ade, 5OHMe-Ura) (49,50)
had very little eﬀect on the progression of WRN exonu-
clease (Table 4). Under our experimental conditions, the
hydroxyl groups at all oxidized positions of DNA lesions
remained predominantly in the oxo form (51–55), suggest-
ing that the diﬀerence in the blockage between purine and
pyrimidine derivatives was not related to tautomerism of
the additional hydroxyl groups.
In our study, Fapy lesions are not imposing more block-
age on WRN exonuclease, than 8oxo-purines. This could
appear surprising, considering the lack of the planar struc-
ture of imidazole ring in Fapy lesions and the reported
moderate blockage of some DNA polymerases in vitro
(9,11). However, it might be explained by the ability
of Fapy lesions to adopt multiple rotameric/tautomeric
forms, with an oxo group at the C8 position, and the
preferential rotameric form of Fapy resembling a two-
ring purine structure, with the stacking between the rele-
vant adjacent base pairs similar to that of 8-oxopurines
situated in the same sequence context (51,52). Due to the
presence of a carbonyl group at C8, and ﬂexibility of the
imidazole fragment, properties of Fapy lesions could
resemble 8oxo-Gua, and thus block WRN exonuclease
similar to 8oxo-Gua. Comparable miscoding properties
of Fapy-Gua and 8oxo-Gua (14), and similar recognition
by 8oxo-Gua glycosylases (48,56) further support this
suggestion.
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Figure 2. Ku stimulation of WRN exonuclease on substrates containing 5OH-Ura and 5OH-Cyt in the digested strand of the substrate.
(A) Ku stimulation of WRN exonuclease past lesions positioned in recessed substrates. Undamaged recessed substrate (15fmol) (left panel or
recessed substrate containing 5OH-Cyt or 5OH-Ura in the digested strand (middle and right panel, respectively), were incubated with the indicated
amounts of WRN protein, in the absence or presence of Ku (128fmol) for 1h at 378C. (B) Ku stimulation of WRN exonuclease activity on forked
substrates. Forked DNA substrates (10 fmol, undamaged or containing a single lesion in the digested strand) were incubated for 15min at 378C with
WRN (20fmol), in the absence or presence of Ku (7.5fmol). Reactions were terminated and reaction products were processed as described for
Figure 1. The positions of the lesions are indicated by the arrows. Und, undamaged substrate; 5OH-Cyt, 5-hydroxycytosine; 5OH-Ura, 5-hydro-
xyuracil, 8oxo-Gua, 8-oxoguanine.
Nucleic Acids Research, 2008, Vol. 36, No. 15 4983Interestingly, 8oxo-Gua and 8oxo-Ade, which are some
of the most eﬃcient inhibitors of WRN exonuclease pro-
gression, have been observed to accumulate with age in
normal individuals (1,15), and in cells from prematurely
aged WS patients (57), indicating that WRN may play a
role in the detection and/or removal of these lesions.
Furthermore, the WRN exonuclease was also blocked
by 5OH-Ura and 5OH-Cyt, which are among the most
frequent derivatives of cytosine, and induce C to T transi-
tions with very high frequencies (18).
The distinct inhibition of WRN exonuclease progres-
sion by base lesions containing a hydroxyl group suggests
that the inhibition may be due to spatial constraints in the
active site of the WRN exonuclease, which might then
impair the catalysis process. An alternative mechanism
by which modiﬁed nucleotides could inhibit the WRN
exonuclease, may be a previously suggested destabilization
of the double-stranded DNA in the proximity of the lesion
(35). As WRN exonuclease is not able to digest single-
stranded DNA (58,59), such changes induced by DNA
modiﬁcations would greatly inﬂuence the progression of
WRN. However, since abasic sites and bulky adducts have
a stronger eﬀect on the stability of the DNA helix com-
pared to minor base modiﬁcations such as 8oxo-Gua and
5OH-Ura (47,60), this putative mechanism of inhibition
seems unlikely. It remains unclear, how a non-distorting
DNA lesion, such as 5-OHU in the non-digested strand,
exerts more of an eﬀect than a missing base.
In contrast to the results obtained with the WRN exo-
nuclease, APE1 exonuclease activity was only moderately
inﬂuenced by the presence of oxidatively-induced lesions
in the digested strand of the substrate. The APE1 exonu-
clease only paused slightly at 5OH-Ura and 5OH-Cyt
lesions, and was not aﬀected by 8oxo-Gua or 8oxo-Ade,
which eﬃciently blocked the WRN exonuclease. The dif-
ferential eﬀect of lesions on APE1 and WRN exonuclease
most likely reﬂects diﬀerences in the structure of the active
sites of the proteins and their modes of DNA binding
(25,61). Our results suggest that recognition of damaged
DNA is likely to be a unique feature of the WRN exonu-
clease and not a general characteristic of all human 30 to 50
exonucleases, which is in agreement with the recent struc-
tural data (24), and the previously suggested role for
WRN as a sensor of DNA damaged bases (40).
Many processes of DNA metabolism on one of the two
strands of double-stranded DNA, involve recognition of
the opposite strand for proper execution. One example is
the single strand cleavage of a DNA substrate by topoi-
somerase I, where the cleavage on one strand is aﬀected
by the presence of abasic sites or G methylation on the
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Figure 3. APE1 exonuclease activity on substrates containing oxidative lesions in the digested strand of the substrate. (A) Forked substrates (14fmol,
undamaged or containing a single lesion in the digested strand) were incubated with APE1 (50fmol) for 15min at 378C. (B) Forked substrates
(5fmol, undamaged or containing 5OH-Ura) were incubated for 15min at 378C with APE1 (140fmol) and Ku (45fmol) as indicated. Positions of the
lesions are indicated by arrows. Reactions were terminated and reaction products were processed as described for Figure 1. Und, undamaged; 8oxo-
Ade, 8-oxoadenine; 8oxo-Gua, 8-oxoguanine; 5OH-Cyt, 5-hydroxycytosine; 5OH-Ura, 5-hydroxyuracil; 5OHMe-Ura, 5-hydroxymethyluracil; 2OH-
Ade, 2-hydroxyadenine.
4984 Nucleic Acids Research, 2008, Vol. 36, No. 15opposite strand (62). Furthermore, the interaction of
E.coli formamidopyrimidine-DNA glycosylase (Fpg) and
human 8-oxoguanine-DNA glycosylase (hOgg1) with
DNA containing a single 8oxo-Gua in one strand,
involves contacting both strands of the DNA duplex
(63). In addition, the yeast XPC orthologue, Rad4, recog-
nizes the undamaged strand of the substrate during
the repair of cyclobutane pyrimidine dimers (64). As the
WRN exonuclease has been proposed to function in the
recognition of damaged DNA bases (40), we investigated
whether WRN progression was also inﬂuenced by lesions
located in the non-digested strand of the substrate. Here,
we show for the ﬁrst time, that digestion by the WRN
exonuclease is inﬂuenced by lesions located in the non-
digested strand, and we demonstrate that 5OH-Ura and
an AP site positioned in the non-digested strand decrease
WRN degradation of the digested strand (Table 4). Our
results suggest that WRN interacts with the non-digested
strand when degrading the opposite strand, consistent
with the ring model of WRN exonuclease proposed by
Perry et al. (24), where both DNA strands appear to con-
tact the exonuclease domain. Furthermore, the mouse
WRN exonuclease appears to work as a multimer (65).
As there is no information currently available regarding
the structure of WRN exonuclease binding longer double-
stranded DNA substrates, more studies are required to
fully explain our results.
It was previously shown that Ku stimulates WRN on
substrates containing the oxidatively induced base lesions
8oxo-Gua and 8oxo-Ade, but not cholesterol or abasic
sites (35). We now present evidence that Ku promotes
WRN bypass of other free-radical-induced lesions as
well, including 5OH-Ura and 5OH-Cyt (Figure 2). Our
results extend the spectrum of lesions on which Ku can
stimulate WRN exonuclease and conﬁrm that the stimula-
tion by Ku is a phenomenon unique to WRN exonuclease,
as no eﬀects of Ku were observed on the exonuclease
activity of APE1. In addition, we demonstrate that Ku
is not able to stimulate the WRN exonuclease to bypass
oxidation-induced lesions which are present in the non-
digested strand. Results by Tainer and co-workers (24)
suggest that Ku may provide a suitable DNA orientation
for the WRN exonuclease, but this does not explain the
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Figure 4. WRN exonuclease activity in the presence of lesions positioned in the non-digested strand of the substrates. (A) Forked substrates (20fmol,
undamaged or containing a single lesion in the non-digested strand) were incubated for 15min at 378C with increasing amounts of WRN (10, 20, 40,
60fmol). (B) Forked substrates (20fmol, undamaged or containing a single lesion in the non-digested strand) were incubated for 15min at 378C
without or with WRN (20fmol) and with Ku (7.5fmol) as indicated. Reactions were terminated and reaction products were processed as described
for Figure 1. Positions of the lesions are indicated by arrows. Und, undamaged; 8oxo-Gua, 8-oxoguanine; AP site, abasic site; 5OH-Ura,
5-hydroxyuracil.
Table 5. Blockage of WRN exonuclease progression by
oxidative lesions in the non-digested strand
Lesion Relative passage (%)
Undamaged 100
8oxo-Gua 102
AP site 87
50H-Ura 67
Nucleic Acids Research, 2008, Vol. 36, No. 15 4985diﬀerence in the eﬀect on the digested versus non-digested
strand.
The genomic instability and cellular senescence exhib-
ited by cells deﬁcient in WRN or Ku, as well as similarities
in the phenotypes of WRN and Ku80 knockout mice
(29,30), suggest that these proteins function in a
common DNA metabolic pathway. Ku and WRN are
likely to participate together in the repair of DSBs via
the non-homologous end joining (NHEJ) pathway, and
cooperatively process the 30 ends at the sites of DNA
breaks (35). This interaction could be even more impor-
tant in the context of DSBs induced by ionizing radiation
and radiomimetic drugs, which are known to generate a
considerable amount of oxidatively induced base lesions in
addition to DNA strand breaks (66).
Due to the observation that both proteins also localize
to telomeres (36,37), the Ku–WRN interaction has been
suggested to play an important role in telomere metabo-
lism, possibly in opening the telomeric D-loop during pro-
cesses of DNA replication and repair (37). It is also likely
that both proteins are involved in the repair of DSBs in
that region. The G-rich regions of telomeres are particu-
larly susceptible to oxidative damage (38,67), and may
contribute to accelerated telomere shortening. As short
telomeres are related to aging, the ability of Ku to stimu-
late the WRN exonuclease to bypass oxidative stress-
induced lesions is likely important during DNA repair
events and further supports the essential role of WRN
and Ku in the maintenance of genome stability.
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